medigraphic.com
Colegio de Medicina Interna de México.

2017, Number 6

<< Back Next >>

Med Int Mex 2017; 33 (6)

Pulmonary micobacteriosis by Mycobacterium abscessus

León-Landa CA, Aguillón-García EA

Language: Spanish
References: 17
Page: 835-840
PDF size: 500.30 Kb.


ABSTRACT

Pulmonary infections due to nontuberculous mycobacteria (NTM) are increasingly recognized worldwide. Chronic respiratory disease is definitely representing a strong risk factor. In the routine practice lung infections by NTM are often overlooked, resulting in delayed diagnosis. Mycobacterium abscessus is the most common etiological agent of lung disease caused by rapidly growing mycobacteria. Diagnosis relies on microbiology and chest CT scanning, and criteria to aid diagnosis are available. We report a case of M. abscessus lung disease in an immunocompetent patient with partial response to treatment.


REFERENCES

  1. Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest 2008;133(1):243-51.

  2. Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis 2014;6(3):210-20.

  3. Barriga-Angulo G, López-Álvarez L, Ramírez-Cruz F, Monzalvo-Hernández ME, Villagrán-Gama JA, Rodríguez- Arreguín E y col. Experiencia de un laboratorio de tercer nivel de atención en el diagnóstico de infecciones por micobacterias. Rev Latinoam Patol Clin Med Lab 2014;61(3):156-162.

  4. Jeon K, Kwon OJ, Lee NY, Kim BJ, et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med 2009;180(9):896-902.

  5. Beltrame A, Cattani G, Screm MC, Brillo F, et al. Successful antibiotic treatment of Mycobacterium abscessus pulmonary disease in an immunocompetent individual. J Infect Dis Ther 2013;1:103. doi:10.4172/2332-0877.1000103

  6. Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother 2012;67(4):810-8.

  7. Leao SC, Tortoli E, Euzeby JP, Garcia MJ. Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus. Int J Syst Evol Microbiol 2011;61: 2311-3.

  8. Castillo-Rodal AI, Mazari-Hiriart M, Lloret-Sánchez LT, Sachman-Ruiz B, et al. Potentially pathogenic nontuberculous mycobacteria found in aquatic systems. Analysis from a reclaimed water and water distribution system in Mexico City. Eur J Clin Microbiol Infect Dis 2012;(31):683-694.

  9. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 2011;52(5):565-71.

  10. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.

  11. Thompson-Bonilla MC, Calderón-Rosete G, Moreno-Sandoval HN, Merino-García JL, Lara-Lozano M, Piña- Leyva C. Epidemiología molecular de infecciones por micobacterias en pacientes del Hospital Regional 1° de Octubre. Rev Esp Méd Quir 2014;19:80-87.

  12. Laniado-Laborín R, Cabrales-Vargas N. No siempre una baciloscopía positiva indica tuberculosis. Otra razón para solicitar cultivos rutinariamente. Rev Inst Nal Enf Resp Méx 2005;18(4):286-289.

  13. Diagnóstico y tratamiento de las infecciones por micobacterias no tuberculosas. México: Secretaría de Salud; 2014.

  14. Choi GE, Shin SJ, Won CJ, Ki-Nam Min, Taegwon Oh, Mi-Young Hahn, et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med 2012;186:917-25.

  15. Lyu J, Kim BJ, Kim BJ, Song J, Choi CM, Oh YM, et al. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease. Respir Med 2014;108(11):1706-12.

  16. Lyu J, Jang HJ, Song JW, Choi CM, Oh YM, Lee SD, et al. Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs. Respir Med 2011;105(5):781-7.

  17. Colombo RE, Olivier KN. Diagnosis and treatment of infections caused by rapidly growing mycobacteria. Semin Respir Crit Care Med 2008;29:577-88.




2020     |     www.medigraphic.com